[HTML][HTML] Beyond Lipoprotein (a) plasma measurements: Lipoprotein (a) and inflammation

G Reyes-Soffer, M Westerterp - Pharmacological research, 2021 - Elsevier
Genome wide association, epidemiological, and clinical studies have established high
lipoprotein (a)[Lp (a)] as a causal risk factor for atherosclerotic cardiovascular disease …

Lipoprotein (a) and inflammation: a dangerous duet leading to endothelial loss of integrity

M Pirro, V Bianconi, F Paciullo, MR Mannarino… - Pharmacological …, 2017 - Elsevier
Abstract Lipoprotein (a)[Lp (a)] is an enigmatic lipoprotein whose ancestral useful properties
have been gradually obscured by its adverse pro-atherogenic and pro-thrombotic effects …

Lipoprotein (a) in atherosclerotic diseases: from pathophysiology to diagnosis and treatment

S Lampsas, M Xenou, E Oikonomou, P Pantelidis… - Molecules, 2023 - mdpi.com
Lipoprotein (a)(Lp (a)) is a low-density lipoprotein (LDL) cholesterol-like particle bound to
apolipoprotein (a). Increased Lp (a) levels are an independent, heritable causal risk factor …

Lipoprotein (a) and atherosclerotic cardiovascular disease: current understanding and future perspectives

MF Wu, KZ Xu, YG Guo, J Yu, Y Wu, LM Lin - Cardiovascular Drugs and …, 2019 - Springer
Purpose To review current knowledge of elevated lipoprotein (a)[Lp (a)] levels in relation to
atherosclerotic cardiovascular disease (ASCVD) and discuss their potential use as …

Lipoprotein (a): current perspectives

I Gouni-Berthold, HK Berthold - Current vascular …, 2011 - ingentaconnect.com
Recent data from genetic and epidemiological studies strongly support a causal relationship
between elevated lipoprotein (a)[Lp (a)] concentrations and the development of …

Lipoprotein (a) and inflammation-pathophysiological links and clinical implications for cardiovascular disease

S Simantiris, AS Antonopoulos, C Papastamos… - Journal of Clinical …, 2023 - Elsevier
The role of lipoprotein (a)(Lp [a]) as a significant and possibly causal cardiovascular disease
(CVD) risk factor has been well established. Many studies, mostly experimental, have …

Lipoprotein (a) and Cardiovascular Diseases―Revisited―

AY Jang, SH Han, IS Sohn, PC Oh, KK Koh - Circulation Journal, 2020 - jstage.jst.go.jp
Two decades ago, it was recognized that lipoprotein (a)(Lp (a)) concentrations were
elevated in patients with cardiovascular disease (CVD). However, the importance of Lp (a) …

Lipoprotein (a)—the crossroads of atherosclerosis, atherothrombosis and inflammation

S Ugovšek, M Šebeštjen - Biomolecules, 2021 - mdpi.com
Increased lipoprotein (a)(Lp (a)) levels are an independent predictor of coronary artery
disease (CAD), degenerative aortic stenosis (DAS), and heart failure independent of CAD …

Lipoprotein (a) in atherosclerosis: from pathophysiology to clinical relevance and treatment options

A Rehberger Likozar, M Zavrtanik… - Annals of medicine, 2020 - Taylor & Francis
Abstract Lipoprotein (a)(Lp (a)) was discovered more than 50 years ago, and a decade later,
it was recognized as a risk factor for coronary artery disease. However, it has gained …

Lipoprotein (a): cellular effects and molecular mechanisms

K Riches, KE Porter - Cholesterol, 2012 - Wiley Online Library
Lipoprotein (a)(Lp (a)) is an independent risk factor for the development of cardiovascular
disease (CVD). Indeed, individuals with plasma concentrations> 20 mg/dL carry a 2‐fold …